These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 36004567)

  • 1. Options for the development of a bivalent vaccine against SARS-CoV-2 and influenza.
    Stepanova E; Isakova-Sivak I; Rudenko L
    Expert Rev Vaccines; 2022 Nov; 21(11):1533-1535. PubMed ID: 36004567
    [No Abstract]   [Full Text] [Related]  

  • 2. A Recombinant VSV-Based Bivalent Vaccine Effectively Protects against Both SARS-CoV-2 and Influenza A Virus Infection.
    Ao Z; Ouyang MJ; Olukitibi TA; Warner B; Vendramelli R; Truong T; Meilleur C; Zhang M; Kung S; Fowke KR; Kobasa D; Yao X
    J Virol; 2022 Sep; 96(18):e0133722. PubMed ID: 36069551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 Vaccine Strain Selection: Guidance From Influenza.
    Monto AS; Lauring AS; Martin ET
    J Infect Dis; 2022 Dec; 227(1):4-8. PubMed ID: 36424890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A combination vaccine against SARS-CoV-2 and H1N1 influenza based on receptor binding domain trimerized by six-helix bundle fusion core.
    Shi R; Zeng J; Xu L; Wang F; Duan X; Wang Y; Wu Z; Yu D; Huang Q; Yao YG; Yan J
    EBioMedicine; 2022 Nov; 85():104297. PubMed ID: 36206623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine models predict rules for updating vaccines against evolving pathogens such as SARS-CoV-2 and influenza in the context of pre-existing immunity.
    Desikan R; Linderman SL; Davis C; Zarnitsyna VI; Ahmed H; Antia R
    Front Immunol; 2022; 13():985478. PubMed ID: 36263031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza Virus and SARS-CoV-2 Vaccines.
    Sandor AM; Sturdivant MS; Ting JPY
    J Immunol; 2021 Jun; 206(11):2509-2520. PubMed ID: 34021048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Future of covid-19 vaccine pricing: lessons from influenza.
    Ramachandran R; Dhodapkar M; Ross JS; Schwartz JL
    BMJ; 2021 Jun; 373():n1467. PubMed ID: 34158283
    [No Abstract]   [Full Text] [Related]  

  • 8. Cross-variant protection against SARS-CoV-2 infection in hamsters immunized with monovalent and bivalent inactivated vaccines.
    Ye ZW; Fan Y; Tang K; Ong CP; Luo C; Chung HL; Leong TL; Liang R; Lui WY; Zhou R; Cheng Y; Lu L; Cheung PH; Chan JF; Chen Z; Yuen KY; Yuan S; To KK; Jin DY
    Int J Biol Sci; 2022; 18(12):4781-4791. PubMed ID: 35874942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection - Increasing Community Access to Testing Program, United States, September-November 2022.
    Link-Gelles R; Ciesla AA; Fleming-Dutra KE; Smith ZR; Britton A; Wiegand RE; Miller JD; Accorsi EK; Schrag SJ; Verani JR; Shang N; Derado G; Pilishvili T
    MMWR Morb Mortal Wkly Rep; 2022 Dec; 71(48):1526-1530. PubMed ID: 36454688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Future of SARS-CoV-2 Vaccination - Lessons from Influenza.
    Monto AS
    N Engl J Med; 2021 Nov; 385(20):1825-1827. PubMed ID: 34739199
    [No Abstract]   [Full Text] [Related]  

  • 11. Tapping the immunological imprints to design chimeric SARS-CoV-2 vaccine for elderly population.
    Biswas A; Mandal RS; Chakraborty S; Maiti G
    Int Rev Immunol; 2022; 41(4):448-463. PubMed ID: 33978550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Technical guidelines for seasonal influenza vaccination in China (2022-2023)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) on Influenza Vaccination
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Oct; 56(10):1356-1386. PubMed ID: 36274602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of SARS-CoV-2 vaccine willingness among people incarcerated in 3 Canadian federal prisons: a cross-sectional study.
    Romanchuk K; Linthwaite B; Cox J; Park H; Dussault C; Basta NE; Varsaneux O; Worthington J; Lebouché B; MacDonald SE; Ismail SJ; Kronfli N
    CMAJ Open; 2022; 10(4):E922-E929. PubMed ID: 36280247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of Booster and Influenza Vaccines against COVID-19 among Healthcare Workers, Taiwan.
    Sim JY; Wu PS; Cheng CF; Chao YC; Yu CH
    Emerg Infect Dis; 2022 Oct; 28(10):2126-2130. PubMed ID: 36037810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thoughts and suggestions on co-administration of seasonal influenza vaccine and COVID-19 vaccine].
    Kou ZQ; Liu LJ; Xu CS; Zhao HT; Zhang ZN; Yang XK; Peng ZB; Feng LZ; Xu AQ; Wang DY; Chen ZP; Zheng JD; Feng ZJ; Yu WZ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Oct; 56(10):1395-1400. PubMed ID: 36274604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antigenicity of SARS-CoV-2 Delta variants aggregated 10 high-frequency mutations in RBD has not changed sufficiently to replace the current vaccine strain.
    Wu J; Nie J; Zhang L; Song H; An Y; Liang Z; Yang J; Ding R; Liu S; Li Q; Li T; Cui Z; Zhang M; He P; Wang Y; Qu X; Hu Z; Wang Q; Huang W
    Signal Transduct Target Ther; 2022 Jan; 7(1):18. PubMed ID: 35046385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A bivalent nanoparticle vaccine exhibits potent cross-protection against the variants of SARS-CoV-2.
    Yuan Y; Zhang X; Chen R; Li Y; Wu B; Li R; Zou F; Ma X; Wang X; Chen Q; Deng J; Zhang Y; Chen T; Lin Y; Yan S; Zhang X; Li C; Bu X; Peng Y; Ke C; Deng K; Pan T; He X; Zhang Y; Zhang H
    Cell Rep; 2022 Jan; 38(3):110256. PubMed ID: 34990583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The new generation of messenger RNA (mRNA) vaccines against influenza.
    Reina J
    Enferm Infecc Microbiol Clin (Engl Ed); 2023 May; 41(5):301-304. PubMed ID: 35906174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Confounding Bias in Coronavirus Disease 2019 (COVID-19) and Influenza Vaccine Effectiveness Test-Negative Designs Due to Correlated Influenza and COVID-19 Vaccination Behaviors.
    Doll MK; Pettigrew SM; Ma J; Verma A
    Clin Infect Dis; 2022 Aug; 75(1):e564-e571. PubMed ID: 35325923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19, seasonal influenza and measles: potential triple burden and the role of flu and MMR vaccines.
    Islam N; Khunti K; Majeed A
    J R Soc Med; 2020 Dec; 113(12):485-486. PubMed ID: 33175649
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.